1. Home
  2. LNTH vs TIMB Comparison

LNTH vs TIMB Comparison

Compare LNTH & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • TIMB
  • Stock Information
  • Founded
  • LNTH 1956
  • TIMB 1998
  • Country
  • LNTH United States
  • TIMB Brazil
  • Employees
  • LNTH N/A
  • TIMB N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TIMB Telecommunications Equipment
  • Sector
  • LNTH Health Care
  • TIMB Telecommunications
  • Exchange
  • LNTH Nasdaq
  • TIMB Nasdaq
  • Market Cap
  • LNTH 7.5B
  • TIMB 8.0B
  • IPO Year
  • LNTH 2015
  • TIMB 1998
  • Fundamental
  • Price
  • LNTH $81.74
  • TIMB $17.18
  • Analyst Decision
  • LNTH Strong Buy
  • TIMB Hold
  • Analyst Count
  • LNTH 5
  • TIMB 4
  • Target Price
  • LNTH $133.80
  • TIMB $17.00
  • AVG Volume (30 Days)
  • LNTH 1.2M
  • TIMB 337.6K
  • Earning Date
  • LNTH 05-07-2025
  • TIMB 05-20-2025
  • Dividend Yield
  • LNTH N/A
  • TIMB 6.92%
  • EPS Growth
  • LNTH N/A
  • TIMB 17.22
  • EPS
  • LNTH 3.53
  • TIMB 0.25
  • Revenue
  • LNTH $1,536,699,000.00
  • TIMB $4,490,458,172.00
  • Revenue This Year
  • LNTH $5.81
  • TIMB $8.10
  • Revenue Next Year
  • LNTH $12.26
  • TIMB $4.87
  • P/E Ratio
  • LNTH $23.15
  • TIMB $13.99
  • Revenue Growth
  • LNTH 12.53
  • TIMB 6.00
  • 52 Week Low
  • LNTH $74.34
  • TIMB $11.32
  • 52 Week High
  • LNTH $126.89
  • TIMB $18.39
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 29.92
  • TIMB 65.35
  • Support Level
  • LNTH $78.92
  • TIMB $17.13
  • Resistance Level
  • LNTH $108.91
  • TIMB $17.68
  • Average True Range (ATR)
  • LNTH 3.82
  • TIMB 0.34
  • MACD
  • LNTH -2.81
  • TIMB 0.09
  • Stochastic Oscillator
  • LNTH 9.40
  • TIMB 76.85

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About TIMB TIM S.A. (Each representing 5)

TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.

Share on Social Networks: